These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29 related articles for article (PubMed ID: 8098589)
21. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review. Reeves ST; Turcasso NM South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301 [TBL] [Abstract][Full Text] [Related]
24. The pharmacoeconomics of neuromuscular blocking drugs. Chiu JW; White PF Anesth Analg; 2000 May; 90(5 Suppl):S19-S23. PubMed ID: 10809514 [No Abstract] [Full Text] [Related]
25. Vecuronium and rocuronium. van den Broek L; Wierda JM; Hennis PJ Anaesthesia; 1993 Apr; 48(4):349. PubMed ID: 8098589 [No Abstract] [Full Text] [Related]
26. Newer neuromuscular blocking agents: how do they compare with established agents? Sparr HJ; Beaufort TM; Fuchs-Buder T Drugs; 2001; 61(7):919-42. PubMed ID: 11434449 [TBL] [Abstract][Full Text] [Related]
27. Update on newer neuromuscular blocking drugs. Holm H; Ostergaard D Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219 [TBL] [Abstract][Full Text] [Related]
28. Sugammadex: the first selective binding reversal agent for neuromuscular block. Kovac AL J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281 [TBL] [Abstract][Full Text] [Related]